Western Midstream Is Now As Expensive As EPD

Analyst reiterates a Strong Buy on Western Midstream, citing that the April call worked with roughly ~25% returns. With much of the rerating to EPD’s multiple likely completed, upside is now expected to come primarily from 7–8% EBITDA growth rather than further multiple expansion. The thesis implies ~15% total returns at a flat multiple, while the ~7.6% yield is more relevant for investors seeking income-only exposure.

Analysis

The key market signal is not the name itself but the fact that a high-quality midstream multiple is being used as the ceiling for the group. That usually lowers the odds of further re-rating and shifts alpha toward names with visible volume growth, not merely generous cash yield; in that setup, EPD becomes the valuation benchmark while smaller midstream peers with weaker coverage are the latent losers. If capital is already treating the space as a quasi-bond proxy, incremental upside will be highly sensitive to rate moves and to whether management can keep growth above the market’s low-teens skepticism.

Near term, the stock should be resilient on yield-seeking flows, but the risk/reward is now more asymmetric to execution: a single softer quarter in EBITDA growth or distribution coverage would likely compress the premium quickly because the multiple story is largely exhausted. The contrarian view is that the market may be underestimating how durable the scarcity value of a top-tier balance sheet is in a slower-growth tape; if funding costs stay elevated, the names that can self-fund growth without equity issuance deserve a persistent premium. Falsifiers are straightforward: growth slipping below the high-single-digit path, leverage ticking up, or a rate rally causing yield buyers to rotate out of the sector before the next print.

Key Decisions for Investors

• Keep EPD as a core income compounder, but do not chase after the rerating; add only on 3-5% pullbacks or if the forward yield re-expands toward ~8%, where the risk/reward improves.
• Use the next quarterly update as the catalyst check: if EBITDA growth prints below ~6% or coverage weakens, cut exposure because the thesis is then just yield support, not compounding.
• Relative-value bias: prefer EPD over lower-quality MLPs with weaker self-funding profiles; the market will punish laggards first if midstream multiple compression resumes.
• If you want to express the view more tactically, sell downside protection rather than chase upside: consider cash-secured put sales on EPD into weakness, targeting premium capture while waiting for a better entry.
• Set a watch alert on 10Y Treasury yields and MLP distribution announcements; a sustained decline in rates would be the main near-term catalyst for another incremental bid, while a surprise rate backup would be the clearest falsifier.